HAMILTON THORNE REPORTS RECORD REVENUE GROWTH FOR QUARTER AND YEAR-ENDED DECEMBER 31, 2016 39% Revenue and 49% EBITDA Growth for the Fourth Quarter BEVERLY, MA and TORONTO, Ontario - April 27, 2017 - Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2016. Sales increased 16.4% to $10.51 million, led by the contribution from its newly acquired Embryotech business, as well as strong growth in sales of LYKOSŪ clinical laser systems and increased...
|
